Disclosed are low-viscosity foamable polyurethane-forming compositions containing a polyol composition having monomeric and higher polyol components and optionally a polyhydroxylated aromatic compound; a polyisocyanate or latent polyisocyanate component or a combination thereof; a blowing agent; and optionally a cyclic carbonate having one or more hydroxyl groups. The monomeric and higher polyols each contain three or more hydroxyl groups, the higher polyol containing residues of the monomeric polyol and optionally residues of the polyhydroxylated aromatic compound, the residues being linked by one or more carbonate and/or ether groups. The Disclosed foamable polyurethane-forming compositions may contain the polyol compositions disclosed; an isocyanate functional component; and a blowing agent. The foamable compositions afford high strength, heat-resistant, low to moderate density foamed-polyurethane compositions useful in a variety of applications including construction, vehicle and packaging applications.

The present invention is directed to coated articles demonstrating a transmission of electromagnetic radiation having a frequency of 22 to 81 GHz in the range of 70% to 100%. The articles comprise substrates coated with curable film-forming compositions comprising a first film-forming polymer prepared from at least one hydrophobic monomer, a second film-forming polymer prepared from at least one hydrophobic monomer, and a curing agent. Upon application of the curable film-forming composition to the substrate to form a coating layer, the first film-forming polymer is distributed throughout the coating layer, and the concentration of the second film-forming polymer is greater at the surface of the coating layer than the concentration of the second film-forming polymer within the bulk of the coating layer. The present invention is also drawn to methods of mitigating contaminant build-up on a substrate using the curable film-forming compositions described above.

Provided is a process for making an ophthalmic devices and ophthalmic devices resulting from the process. The process comprises: (a) providing a first reactive composition containing: (i) a polymerization initiator that is capable, upon a first activation, of forming two or more free radical groups, at least one of which is further activatable by subsequent activation; (ii) one or more ethylenically unsaturated compounds; and (iii) a crosslinker; (b) subjecting the first reactive composition to a first activation step such that the first reactive composition polymerizes therein to form a crosslinked substrate network containing a covalently bound activatable free radical initiator; (c) contacting the crosslinked substrate network with a grafting composition containing a shrinking agent and one or more ethylenically unsaturated compounds; and (d) activating the covalently bound activatable free radical initiator of the crosslinked substrate network such that the grafting composition polymerizes therein with the crosslinked substrate network.

Provided is a process for making an ophthalmic devices and ophthalmic devices resulting from the process. The process comprises: (a) providing a first reactive composition containing: (i) a polymerization initiator that is capable, upon a first activation, of forming two or more free radical groups, at least one of which is further activatable by subsequent activation; (ii) one or more ethylenically unsaturated compounds; and (iii) a crosslinker; (b) subjecting the first reactive composition to a first activation step such that the first reactive composition polymerizes therein to form a crosslinked substrate network containing a covalently bound activatable free radical initiator; (c) contacting the crosslinked substrate network with a grafting composition containing a shrinking agent and one or more ethylenically unsaturated compounds; and (d) activating the covalently bound activatable free radical initiator of the crosslinked substrate network such that the grafting composition polymerizes therein with the crosslinked substrate network.

Disclosed herein are kits for use in adding degradable foam to a tire, methods for preparing a degradable foam-containing tire, tires containing degradable foam, and methods for degrading the degradable foam in tires containing degradable foam. The degradable foam comprises a combination of (i) at least one di- or polyisocyanate, (ii) at least one polysiloxane diol, at least one polysiloxane diamine, or a combination thereof, and (iii) optionally at least one polyol.

Disclosed herein are kits for use in adding degradable foam to a tire, methods for preparing a degradable foam-containing tire, tires containing degradable foam, and methods for degrading the degradable foam in tires containing degradable foam. The degradable foam comprises a combination of (i) at least one di- or polyisocyanate, (ii) at least one polysiloxane diol, at least one polysiloxane diamine, or a combination thereof, and (iii) optionally at least one polyol.

The invention relates to curable coating compositions containing at least one surface modifying amphiphilic additive; and at least one siloxane-polyurethane coating composition. The invention also relates to methods of making and using the curable coating compositions of the invention. The invention also relates to objects coated with the curable coating composition of the invention. The invention also relates to methods for reducing or preventing biofouling of a surface exposed to an aqueous environment comprising the steps of coating the surface with the curable coating composition of the invention to form a coated surface, and curing the coating composition on the coated surface. The invention also relates to a marine fouling-release coating containing the curable coating composition of the invention.

A biomedical device is disclosed which is a polymerization product of a mixture comprising (a) one or more difunctional isocyanates; (b) one or more polyalcohols; (c) one or more hydroxy-terminated polysiloxane prepolymers; and (d) one or more polyoxazoline polyols having a weight average molecular weight of equal to or greater than about 1000 Daltons.

A biomedical device is disclosed which is a polymerization product of a mixture comprising (a) one or more difunctional isocyanates; (b) one or more polyalcohols; (c) one or more hydroxy-terminated polysiloxane prepolymers; and (d) one or more polyoxazoline polyols having a weight average molecular weight of equal to or greater than about 1000 Daltons.

A preparation method for an ultraviolet-responsive coumarin controlled-release and self-repairing anti-fouling paint includes: reacting double-end-group reactive polydimethylsiloxane, polyisocyanate, and an organic diluting solvent; adding a dihydroxycoumarin compound, a cross-linking agent and an organotin catalyst; adding a simple coumarin compound, and irradiating the mixture with 365 nm ultraviolet light to obtain the anti-fouling paint. An anti-fouling coat formed by the paint of the present invention has the advantages of controllable release of a coumarin green anti-fouling agent in response to external ultraviolet stimulation and self-repairing, and the problems that the release of the conventional anti-fouling agents in the anti-fouling coat is difficult to control, and that the low-surface-energy anti-fouling coat is difficult to repair after being damaged are solved. The anti-fouling application requirements of various shallow sea light-transmitting constructions can be met, the service life is prolonged, and the application performance in a complex real sea environment is enhanced.